Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation.

"data availability raw and processed data are available under geo gse242994. data availability raw and processed data are available under geo gse242994"

"Declarations Conflicts of interestSR is at the Advisory Board of Bayer, Novartis, BMS and Roche, at the Data Monitoring and Safety Committee of Celgene, performs assessment for the German Children`s Cancer Foundation and consulting for MyChildsCancer. Conflicts of interest SR is at the Advisory Board of Bayer, Novartis, BMS and Roche, at the Data Monitoring and Safety Committee of Celgene, performs assessment for the German Children`s Cancer Foundation and consulting for MyChildsCancer."

"Funding Open Access funding enabled and organized by Projekt DEAL. US was supported by the Deutsche Forschungsgemeinschaft and the Fördergemeinschaft Kinderkrebszentrum Hamburg. SN received a grant of the University Cancer Center Hamburg. AE was supported within the interdisciplinary graduate school “Innovative Technologies in Cancer Diagnostics and Therapy” funded by the City of Hamburg. This study was supported by the Grant-in-Aid for JSPS Fellows by the Japan Society for the Promotion of Science (grant no. 21J10625) and the Takeda Science Foundation. AKS is a fellow of the Hertie Academy of Excellence in Clinical Neuroscience. SR received financial support for the HIT2000 trial from the German Childrens Cancer Foundation, Bonn."